Early pathophysiological features in canine renal papillary necrosis induced by nefiracetam

Toxicologic Pathology

Volumn 33, Issue 5, 2005, Pages 561-569

  Tsuchiya, Yoshimi ^a,b   Yabe, Koichi ^a   Takada, Sanae ^a   Ishii, Yoshikazu ^a   Jindo, Toshimasa ^a   Furuhama, Kazuhisa ^a   Suzuki, Kazuo T ^b  

^a DAIICHI SANKYO CO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Dog; Ibuprofen; Nefiracetam; Renal papillary necrosis

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; LACTATE DEHYDROGENASE; MESSENGER RNA; NEFIRACETAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOG; DRUG STRUCTURE; ELECTRON MICROSCOPY; ENZYME ASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; KIDNEY PAPILLA; KIDNEY PAPILLA NECROSIS; LABORATORY TEST; MALE; MICROSCOPY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URINE OSMOLALITY; URINE VOLUME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOGS; EPITHELIAL CELLS; IBUPROFEN; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; KIDNEY PAPILLARY NECROSIS; MALE; MICROVILLI; MOLECULAR STRUCTURE; NEUROTRANSMITTER AGENTS; PYRROLIDINONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 26944460424     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230500222593     Document Type: Article

References (32)

1. Abe, E., Murai, S., Saito, H., Masuda, Y., Takasu, Y., Shiotani, T., Tachizawa, H., and Itoh, T. (1994). Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF 64A in mice. J Neural Transm 95, 179-93.
2. Alden, C. L., and Frith, C. H. (1991). Urinary system. In Handbook of Toxicologic Pathology (W. M. Haschek and C. G. Rousseaux, eds.), pp. 347-8, Academic Press, New York.
3. Bach, P. H., Scholey, D. J., Delacruz, L., Moret, M., and Nichol, S. (1991). Renal and urinary lipid changes associated with an acutely induced renal papillary necrosis in rats. Fd Chem Toxic 29, 211-19.
4. Bach, P. H., and Thanh, N. T. K. (1998). Renal papillary necrosis-40 years on. Toxicol Pathol 26, 73-91.
5. Bachmann, S., and Kriz, W. (1982). Histotopography and ultrastructure of thin limbs of loop of Henle in the hamster. Cell Tissue Res 225, 111-27.
6. Collares-Buzato, C. B., Jepson, M. A., Simmons, N. L., and Hirst, B. H. (1998). Increased thyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. Eur J Cell Biol 76, 85-92.
7. Cotran, R. S., Kumar, V., and Collins, T. (1999). Cellular pathology I: Cell injury and cell death. In Robbins Pathologic Basis of Disease, 6th edition, pp. 1-29. W. B. Saunders Company, Philadelphia.
8. George, S. K., Meyer, T. N., Abdeen, O., Bush, K. T., and Nigam, S. K. (2004). Tunicamycin preserves intercellular junctions, cytoarchitecture and cell-substratum interactions in ATP-depleted epithelial cells. Biochem Biophys Res Commun 322, 223-31.
9. Goto, K., Ishii, Y., Jindo, T., and Furuhama, K. (2003). Effect of nefiracetam, a neurotransmission enhancer, on primary uroepithelial cells of the canine urinary bladder. Toxicol Pathol 72, 164-70.
10. Hao, C. M., Yull, F., Blackwell, T., Kömhoff, M., Davis, L. S., and Breyer, M. D. (2000). Dehydration activates an NF-κB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. J Clin Invest 106, 973-82.
11. Hiramatsu, M., Koide, T., Ishihara, S., Shiotani, T., Kameyama, T., and Nabeshima, T. (1992). Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia. Eur J Pharmacol 216, 279-85.
12. Hooks, W. N., Colman, K. A., Gopinath, C., Inage, F., Kato, M., and Takayama, S. (1994). Fifty-two week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats. Arzneimitelforschung 44, 220-8.
13. Jindo, T., Shimizu, Y., Kato, M., and Takayama, S. (1994). Thirteen-week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats. Arzneimitelforschung 44, 214-6.
14. Johnson, L. G. (2005). Applications of imaging techniques to studies of epithelial tight junctions. Adv Drug Deliv Rev. 57, 111-21.
15. Kajimura, T., Satoh, H., Rajasekaran, D., Spicer, E. J. F., Nakashima, N., and Takayama, S. (1994). Oncogenicity studies of the cognition-enhancing agent nefiracetam in mice and rats. Arzneimitelforschung 44, 254-9.
16. Kashida, Y., Yoshida, M., Ishii, Y., Nomura, M., and Kato, M. (1996). Examination of lesions in the urinary bladder and kidney of dogs induced by nefiracetam, a new nootropic agent. Toxicol Pathol 24, 549-57.
17. Khan, K. N. M., Alden, C. L., Gleissner, S. E., Gessford, M. K., and Maziasz, T. J. (1998). Effects of papillotoxic agents on expression of cyclooxygenase isoforms in the rat kidney. Toxicol Pathol 26, 137-42.
18. Khan, K. N. M., and Silverman, L. R. (1999). "Have you seen this?" Nonsteroidal Anti-inflammatory drug-induced renal papillary necrosis in a dog. Toxicol Pathol 27, 244-5.
19. Kolaja, G. J., Packwood, W. H., Bell, R. R., Ratke, C. C., and Stout, C. L. (1994). Renal papillary necrosis and urinary protein alterations induced in Fischer-344 rats by D-ormaplatin. Toxicol Pathol 22, 29-38.
20. Nabeshima, T. (1994). Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction. Drugs Today 30, 357-79.
21. Nabeshima, T., Nakayama, S., Ichihara, K., Yamada, K., Shiotani, T., and Hasegawa, T. (1994). Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task. Eur J Pharmacol 255, 57-65.
22. Neuhofer, W., Hozapfel, K., Fraek, M. L., Ouyang, N., Lutz, J., and Beck, F. X. (2004). Chronic COX-2 inhibition reduces medullary HSP70 expression and induces papillary apoptosis in dehydrated rats. Kidney Int 65, 431-441.
23. Nishizaki, T., Matsuoka, T., Nomura, T., Sumikawa, K., Shiotani, T., Watabe, S., and Yoshii, M. (1998). Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. Mol Pharmacol 53, 1-5.
24. Rocha, G. M., Michea, L. F., Peters, E. M., Kirby, M., Xu, Y, Ferguson, D. R., and Burg, M. B. (2001). Direct toxicity of nonsteroidal anti-inflammatory drugs for renal medullary cells. Proc Natl Acad Sci USA 98, 5317-5322.
25. Sabatini, S. (1984). The pathophysiology of experimentally induced renal papillary necrosis. Semin Nephrol 4, 27-38.
26. Sabatini, S. (1988). Analgesic-induced papillary necrosis. Semin Nephrol 9, 41-54.
27. Sakurai, T., Ojima, H., Yamasaki, T., Kojima, H., and Akashi, A. (1989). Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384) on learning and memory in rats. Jpn J Pharmacol 50, 47-53.
28. Sellers, R. S., Senese, P. B., and Khan, K. N. M. (2004). Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition. Drug Chem Toxicol 27, 111-22.
29. Sudo, K., Hashimoto, K., Fujimaki, Y., and Tachizawa, H. (1988). Abstracts of the Collegium Internationale Neuro-Phychopharmacologium Congress, Munich, No. 32.02.25.
30. Tsuchiya, Y., Takahashi, Y., Jindo, T., Furuhama, K., and Suzuki, K. T. (2003). Comprehensive evaluation of canine renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer. Eur J Pharmacol 475, 119-28.
31. Whiting, P. H., Tisocki, K., and Hawksworth, G. M. (1999). Human renal medullary interstitial cells and analgesic nephropathy. Renal Fail 21, 387-92.
32. William, M., William, L. H., and Jeffrey, S. S. (1996). The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 28, S56-S62.